{"id":343057,"date":"2026-11-10T11:49:26","date_gmt":"2026-11-10T06:19:26","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=343057"},"modified":"2026-11-10T11:49:26","modified_gmt":"2026-11-10T06:19:26","slug":"defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/","title":{"rendered":"3 Defence and Space Optics Company, Pharmaceutical Company and Global IT Services Company Stocks With a Strong Future Roadmap: Paras Defence and Space Technologies, Eris Lifesciences and Tech Mahindra"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Paras Defence and Space Technologies, Eris Lifesciences and Tech Mahindra: ROE of 12.1% to 18.6% and FY22 to FY26 revenue CAGR of 5.6% to 27.6%. Prices as of 9 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three defence electronics, pharma and IT stocks to watch are Paras Defence and Space Technologies, Eris Lifesciences and Tech Mahindra. Their return on equity ranges from 12.1% to 18.6%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.6% to 27.6%. Tech Mahindra has the highest return on equity at 18.6%, while Paras Defence and Space Technologies has the fastest revenue growth at 27.6% a year. Prices are based on the 9 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Defence electronics, pharma and IT stocks offer a focused view of a sector where demand keeps widening. Paras Defence and Space Technologies, Eris Lifesciences and Tech Mahindra cover a defence and space optics company, a pharmaceutical company and a global IT services company.<\/p>\n<p>This list covers three defence electronics, pharma and IT stocks with complete current figures: Paras Defence and Space Technologies, Eris Lifesciences and Tech Mahindra. Every figure comes from the latest reported financials and the 9 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#What_Are_Defence_Electronics_Pharma_and_IT_Stocks\" title=\"What Are Defence Electronics, Pharma and IT Stocks?\">What Are Defence Electronics, Pharma and IT Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#Defence_Electronics_Pharma_and_IT_Stocks_at_a_Glance\" title=\"Defence Electronics, Pharma and IT Stocks at a Glance\">Defence Electronics, Pharma and IT Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#Why_Do_Defence_Electronics_Pharma_and_IT_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Defence Electronics, Pharma and IT Stocks Have a Strong Roadmap in India?\">Why Do Defence Electronics, Pharma and IT Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#Why_Paras_Defence_and_Space_Technologies_Features_Among_These_Defence_Electronics_Pharma_and_IT_Stocks\" title=\"Why Paras Defence and Space Technologies Features Among These Defence Electronics, Pharma and IT Stocks\">Why Paras Defence and Space Technologies Features Among These Defence Electronics, Pharma and IT Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#Why_Eris_Lifesciences_Features_Among_These_Defence_Electronics_Pharma_and_IT_Stocks\" title=\"Why Eris Lifesciences Features Among These Defence Electronics, Pharma and IT Stocks\">Why Eris Lifesciences Features Among These Defence Electronics, Pharma and IT Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#Why_Tech_Mahindra_Features_Among_These_Defence_Electronics_Pharma_and_IT_Stocks\" title=\"Why Tech Mahindra Features Among These Defence Electronics, Pharma and IT Stocks\">Why Tech Mahindra Features Among These Defence Electronics, Pharma and IT Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#Paras_Defence_and_Space_Technologies_vs_Eris_Lifesciences_vs_Tech_Mahindra_on_Key_Financials\" title=\"Paras Defence and Space Technologies vs Eris Lifesciences vs Tech Mahindra on Key Financials\">Paras Defence and Space Technologies vs Eris Lifesciences vs Tech Mahindra on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#Key_Risks_to_Check_Before_Investing_in_Defence_Electronics_Pharma_and_IT_Stocks\" title=\"Key Risks to Check Before Investing in Defence Electronics, Pharma and IT Stocks\">Key Risks to Check Before Investing in Defence Electronics, Pharma and IT Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#Final_Thoughts_on_Defence_Electronics_Pharma_and_IT_Stocks\" title=\"Final Thoughts on Defence Electronics, Pharma and IT Stocks\">Final Thoughts on Defence Electronics, Pharma and IT Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#What_are_defence_electronics_pharma_and_IT_stocks\" title=\"What are defence electronics, pharma and IT stocks?\">What are defence electronics, pharma and IT stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#Which_defence_electronics_pharma_and_IT_stocks_are_covered_in_this_list\" title=\"Which defence electronics, pharma and IT stocks are covered in this list?\">Which defence electronics, pharma and IT stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#Why_do_defence_electronics_pharma_and_IT_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do defence electronics, pharma and IT stocks have a strong future roadmap in India?\">Why do defence electronics, pharma and IT stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#How_has_Paras_Defence_and_Space_Technologies_performed_financially\" title=\"How has Paras Defence and Space Technologies performed financially?\">How has Paras Defence and Space Technologies performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#How_has_Eris_Lifesciences_performed_financially\" title=\"How has Eris Lifesciences performed financially?\">How has Eris Lifesciences performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#How_has_Tech_Mahindra_performed_financially\" title=\"How has Tech Mahindra performed financially?\">How has Tech Mahindra performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#What_risks_should_investors_check_before_buying_defence_electronics_pharma_and_IT_stocks\" title=\"What risks should investors check before buying defence electronics, pharma and IT stocks?\">What risks should investors check before buying defence electronics, pharma and IT stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/defence-and-space-optics-company-pharmaceutical-company-and-global-it-services-company-stocks-roadmap-outcrop-list\/#Is_this_list_of_defence_electronics_pharma_and_IT_stocks_investment_advice\" title=\"Is this list of defence electronics, pharma and IT stocks investment advice?\">Is this list of defence electronics, pharma and IT stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Defence_Electronics_Pharma_and_IT_Stocks\"><\/span><strong>What Are Defence Electronics, Pharma and IT Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Defence electronics, pharma and IT stocks are listed companies that build optics, electronics and systems for defence and space, develop and sell branded medicines for chronic and lifestyle conditions, and provide IT and telecom services to global clients. Their earnings depend on programme orders, prescription demand and client technology budgets.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Defence_Electronics_Pharma_and_IT_Stocks_at_a_Glance\"><\/span><strong>Defence Electronics, Pharma and IT Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/paras\/paras-defence-and-space-technologies-ltd-share-price-today\">Paras Defence and Space Technologies<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,249.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10,193<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">106.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">48.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.04<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/eris\/eris-lifesciences-ltd-share-price-today\">Eris Lifesciences<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,252.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15,618<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.60<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/techm\/tech-mahindra-ltd-share-price-today\">Tech Mahindra<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,829.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">175,398<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">31.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.07<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Eris Lifesciences trades at a P\/E below the industry P\/E, while Paras Defence and Space Technologies and Tech Mahindra trade above it, which reflects the growth the market already expects. Readers comparing defence electronics, pharma and IT stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in defence electronics, pharma and IT stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Defence_Electronics_Pharma_and_IT_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Defence Electronics, Pharma and IT Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Defence electronics, pharma and IT stocks have a strong roadmap in India because strong defence indigenisation, steady demand for chronic care medicines and rising global spending on digital services keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Defence optics.<\/strong> Armed forces need home built sensors.<\/li>\n<li><strong>Pharma.<\/strong> Doctors prescribe branded medicines widely.<\/li>\n<li><strong>IT services.<\/strong> Telecom and enterprise clients invest in networks.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Paras_Defence_and_Space_Technologies_Features_Among_These_Defence_Electronics_Pharma_and_IT_Stocks\"><\/span><strong>Why Paras Defence and Space Technologies Features Among These Defence Electronics, Pharma and IT Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the defence electronics, pharma and IT stocks on this list, Paras Defence and Space Technologies makes optics and electro-optics, defence electronics, heavy engineering products and space optics, and serves the defence, space and homeland security markets.<\/p>\n<p>In the June 2026 quarter, revenue grew 35.9% year on year to Rs 130 crore, while net profit rose 45.3% to Rs 20.7 crore. Revenue rose from Rs 186 crore in FY22 to Rs 493 crore in FY26, a compound annual growth rate of 27.6%.<\/p>\n<p>Net profit grew from Rs 27.1 crore in FY22 to Rs 89.5 crore in FY26, which works out to a compound annual growth rate of 34.8%. The company has a return on equity of 12.1%, a debt to equity ratio of 0.04 and a market capitalisation of Rs 10,193 crore. The stock trades at a P\/E of 106.3, above the industry P\/E of 48.1.<\/p>\n<p><strong>Roadmap:<\/strong> The company is among the few Indian private players in defence optics and has been adding capabilities in thermal imaging, anti-drone systems and space applications. Its products meet a steady need for indigenous sensors, optics and surveillance equipment.<\/p>\n<p><strong>What to watch:<\/strong> Track new order wins in optics and the progress of its newer product lines such as anti-drone and space-grade systems.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Eris_Lifesciences_Features_Among_These_Defence_Electronics_Pharma_and_IT_Stocks\"><\/span><strong>Why Eris Lifesciences Features Among These Defence Electronics, Pharma and IT Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the optics, medicine and technology shares on this list, Eris Lifesciences is an Indian pharmaceutical company with branded formulations in chronic therapies such as cardiac, diabetes and gastro-intestinal care, along with an injectables business.<\/p>\n<p>The company has a return on equity of 15.9%, a debt to equity ratio of 0.60 and a market capitalisation of Rs 15,618 crore. The stock trades at a P\/E of 23.5, below the industry P\/E of 36.0.<\/p>\n<p>Revenue rose from Rs 1,373 crore in FY22 to Rs 3,137 crore in FY26, a compound annual growth rate of 22.9%. Net profit grew from Rs 406 crore in FY22 to Rs 648 crore in FY26, which works out to a compound annual growth rate of 12.4%. In the June 2026 quarter, revenue grew 12.9% year on year to Rs 876 crore, while net profit rose 14.6% to Rs 143 crore.<\/p>\n<p><strong>Roadmap:<\/strong> Its portfolio expansion, including the addition of branded domestic formulations from other companies and its injectables unit, widens its reach with doctors. Chronic therapy brands bring repeat prescriptions, which supports steady revenue.<\/p>\n<p><strong>What to watch:<\/strong> Check how smoothly acquired brands are integrated and how the injectables unit scales.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Tech_Mahindra_Features_Among_These_Defence_Electronics_Pharma_and_IT_Stocks\"><\/span><strong>Why Tech Mahindra Features Among These Defence Electronics, Pharma and IT Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Tech Mahindra is a Mahindra Group technology services company that provides digital, network and enterprise services to clients in telecom, manufacturing, banking and other industries worldwide.<\/p>\n<p>Revenue rose from Rs 45,758 crore in FY22 to Rs 56,847 crore in FY26, a compound annual growth rate of 5.6%. Net profit grew from Rs 2,397 crore in FY24 to Rs 4,806 crore in FY26, which works out to a compound annual growth rate of 41.6%.<\/p>\n<p>The company has a return on equity of 18.6%, a debt to equity ratio of 0.07 and a market capitalisation of Rs 175,398 crore. The stock trades at a P\/E of 31.5, above the industry P\/E of 17.6.<\/p>\n<p><strong>Roadmap:<\/strong> The company is investing in artificial intelligence, cloud and 5G related services and deepening ties with large clients. Large deal wins in telecom and enterprise work support its pipeline.<\/p>\n<p><strong>What to watch:<\/strong> Track large deal wins, margin improvement and demand from telecom and enterprise clients.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Paras_Defence_and_Space_Technologies_vs_Eris_Lifesciences_vs_Tech_Mahindra_on_Key_Financials\"><\/span><strong>Paras Defence and Space Technologies vs Eris Lifesciences vs Tech Mahindra on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three defence electronics, pharma and IT stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Paras Defence and Space Technologies<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">186<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">493<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">27.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">89.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Eris Lifesciences<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,373<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,137<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.9%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">648<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Tech Mahindra<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">45,758<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">56,847<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,806<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.5%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Tech Mahindra posts the highest return on equity in this group at 18.6%. Tech Mahindra has the largest FY26 revenue at Rs 56,847 crore, and Paras Defence and Space Technologies shows the fastest revenue growth with a 27.6% compound annual rate. A useful habit with defence electronics, pharma and IT stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Defence_Electronics_Pharma_and_IT_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Defence Electronics, Pharma and IT Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these defence electronics, pharma and IT stocks, the main points are: Long-term optics, medicine and technology shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Order timing.<\/strong> Defence and space orders can shift between periods.<\/li>\n<li><strong>Client spending.<\/strong> Technology budgets can vary with global conditions.<\/li>\n<li><strong>Valuation levels.<\/strong> Some of these companies trade at high earnings multiples, so growth must continue to justify them.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter defence electronics, pharma and IT stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Defence_Electronics_Pharma_and_IT_Stocks\"><\/span><strong>Final Thoughts on Defence Electronics, Pharma and IT Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Defence electronics, pharma and IT stocks reward patient research into demand, execution and financial strength. Paras Defence and Space Technologies, Eris Lifesciences and Tech Mahindra each have a clear plan to grow. Based on the 9 November 2026 close, Paras Defence and Space Technologies trades at Rs 1,249.1, Eris Lifesciences at Rs 1,252.7 and Tech Mahindra at Rs 1,829.9. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these defence electronics, pharma and IT stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track defence electronics, pharma and IT stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_defence_electronics_pharma_and_IT_stocks\"><\/span><strong>What are defence electronics, pharma and IT stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Defence electronics, pharma and IT stocks are listed companies that build optics, electronics and systems for defence and space, develop and sell branded medicines for chronic and lifestyle conditions, and provide IT and telecom services to global clients. Their earnings depend on programme orders, prescription demand and client technology budgets. This list looks at three of them, Paras Defence and Space Technologies, Eris Lifesciences and Tech Mahindra, using reported FY22 to FY26 financials and the 9 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_defence_electronics_pharma_and_IT_stocks_are_covered_in_this_list\"><\/span><strong>Which defence electronics, pharma and IT stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Paras Defence and Space Technologies, Eris Lifesciences and Tech Mahindra. Based on the 9 November 2026 close, Paras Defence and Space Technologies traded at Rs 1,249.1, Eris Lifesciences at Rs 1,252.7 and Tech Mahindra at Rs 1,829.9. Their return on equity ranges from 12.1% to 18.6%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.6% to 27.6%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_defence_electronics_pharma_and_IT_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do defence electronics, pharma and IT stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Defence electronics, pharma and IT stocks have a strong roadmap in India because strong defence indigenisation, steady demand for chronic care medicines and rising global spending on digital services keep widening the market for these companies. The main drivers are as follows. Defence optics. Armed forces need home built sensors. Pharma. Doctors prescribe branded medicines widely. IT services. Telecom and enterprise clients invest in networks. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Paras_Defence_and_Space_Technologies_performed_financially\"><\/span><strong>How has Paras Defence and Space Technologies performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 186 crore in FY22 to Rs 493 crore in FY26, a compound annual growth rate of 27.6%. Net profit grew from Rs 27.1 crore in FY22 to Rs 89.5 crore in FY26, which works out to a compound annual growth rate of 34.8%. In the June 2026 quarter, revenue grew 35.9% year on year to Rs 130 crore, while net profit rose 45.3% to Rs 20.7 crore. The company has a return on equity of 12.1%, a debt to equity ratio of 0.04 and a market capitalisation of Rs 10,193 crore. The stock trades at a P\/E of 106.3, above the industry P\/E of 48.1. Looking ahead, the company is among the few Indian private players in defence optics and has been adding capabilities in thermal imaging, anti-drone systems and space applications. Its products meet a steady need for indigenous sensors, optics and surveillance equipment.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Eris_Lifesciences_performed_financially\"><\/span><strong>How has Eris Lifesciences performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,373 crore in FY22 to Rs 3,137 crore in FY26, a compound annual growth rate of 22.9%. Net profit grew from Rs 406 crore in FY22 to Rs 648 crore in FY26, which works out to a compound annual growth rate of 12.4%. In the June 2026 quarter, revenue grew 12.9% year on year to Rs 876 crore, while net profit rose 14.6% to Rs 143 crore. The company has a return on equity of 15.9%, a debt to equity ratio of 0.60 and a market capitalisation of Rs 15,618 crore. The stock trades at a P\/E of 23.5, below the industry P\/E of 36.0. Looking ahead, its portfolio expansion, including the addition of branded domestic formulations from other companies and its injectables unit, widens its reach with doctors. Chronic therapy brands bring repeat prescriptions, which supports steady revenue.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Tech_Mahindra_performed_financially\"><\/span><strong>How has Tech Mahindra performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 45,758 crore in FY22 to Rs 56,847 crore in FY26, a compound annual growth rate of 5.6%. Net profit grew from Rs 2,397 crore in FY24 to Rs 4,806 crore in FY26, which works out to a compound annual growth rate of 41.6%. The company has a return on equity of 18.6%, a debt to equity ratio of 0.07 and a market capitalisation of Rs 175,398 crore. The stock trades at a P\/E of 31.5, above the industry P\/E of 17.6. Looking ahead, the company is investing in artificial intelligence, cloud and 5G related services and deepening ties with large clients. Large deal wins in telecom and enterprise work support its pipeline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_defence_electronics_pharma_and_IT_stocks\"><\/span><strong>What risks should investors check before buying defence electronics, pharma and IT stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying defence electronics, pharma and IT stocks. Order timing. Defence and space orders can shift between periods. Client spending. Technology budgets can vary with global conditions. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_defence_electronics_pharma_and_IT_stocks_investment_advice\"><\/span><strong>Is this list of defence electronics, pharma and IT stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 9 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are defence electronics, pharma and IT stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Defence electronics, pharma and IT stocks are listed companies that build optics, electronics and systems for defence and space, develop and sell branded medicines for chronic and lifestyle conditions, and provide IT and telecom services to global clients. Their earnings depend on programme orders, prescription demand and client technology budgets. This list looks at three of them, Paras Defence and Space Technologies, Eris Lifesciences and Tech Mahindra, using reported FY22 to FY26 financials and the 9 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which defence electronics, pharma and IT stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Paras Defence and Space Technologies, Eris Lifesciences and Tech Mahindra. Based on the 9 November 2026 close, Paras Defence and Space Technologies traded at Rs 1,249.1, Eris Lifesciences at Rs 1,252.7 and Tech Mahindra at Rs 1,829.9. Their return on equity ranges from 12.1% to 18.6%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.6% to 27.6%.\"}},{\"@type\":\"Question\",\"name\":\"Why do defence electronics, pharma and IT stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Defence electronics, pharma and IT stocks have a strong roadmap in India because strong defence indigenisation, steady demand for chronic care medicines and rising global spending on digital services keep widening the market for these companies. The main drivers are as follows. Defence optics. Armed forces need home built sensors. Pharma. Doctors prescribe branded medicines widely. IT services. Telecom and enterprise clients invest in networks. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Paras Defence and Space Technologies performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 186 crore in FY22 to Rs 493 crore in FY26, a compound annual growth rate of 27.6%. Net profit grew from Rs 27.1 crore in FY22 to Rs 89.5 crore in FY26, which works out to a compound annual growth rate of 34.8%. In the June 2026 quarter, revenue grew 35.9% year on year to Rs 130 crore, while net profit rose 45.3% to Rs 20.7 crore. The company has a return on equity of 12.1%, a debt to equity ratio of 0.04 and a market capitalisation of Rs 10,193 crore. The stock trades at a P\/E of 106.3, above the industry P\/E of 48.1. Looking ahead, the company is among the few Indian private players in defence optics and has been adding capabilities in thermal imaging, anti-drone systems and space applications. Its products meet a steady need for indigenous sensors, optics and surveillance equipment.\"}},{\"@type\":\"Question\",\"name\":\"How has Eris Lifesciences performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,373 crore in FY22 to Rs 3,137 crore in FY26, a compound annual growth rate of 22.9%. Net profit grew from Rs 406 crore in FY22 to Rs 648 crore in FY26, which works out to a compound annual growth rate of 12.4%. In the June 2026 quarter, revenue grew 12.9% year on year to Rs 876 crore, while net profit rose 14.6% to Rs 143 crore. The company has a return on equity of 15.9%, a debt to equity ratio of 0.60 and a market capitalisation of Rs 15,618 crore. The stock trades at a P\/E of 23.5, below the industry P\/E of 36.0. Looking ahead, its portfolio expansion, including the addition of branded domestic formulations from other companies and its injectables unit, widens its reach with doctors. Chronic therapy brands bring repeat prescriptions, which supports steady revenue.\"}},{\"@type\":\"Question\",\"name\":\"How has Tech Mahindra performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 45,758 crore in FY22 to Rs 56,847 crore in FY26, a compound annual growth rate of 5.6%. Net profit grew from Rs 2,397 crore in FY24 to Rs 4,806 crore in FY26, which works out to a compound annual growth rate of 41.6%. The company has a return on equity of 18.6%, a debt to equity ratio of 0.07 and a market capitalisation of Rs 175,398 crore. The stock trades at a P\/E of 31.5, above the industry P\/E of 17.6. Looking ahead, the company is investing in artificial intelligence, cloud and 5G related services and deepening ties with large clients. Large deal wins in telecom and enterprise work support its pipeline.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying defence electronics, pharma and IT stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying defence electronics, pharma and IT stocks. Order timing. Defence and space orders can shift between periods. Client spending. Technology budgets can vary with global conditions. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of defence electronics, pharma and IT stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 9 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Defence Electronics, Pharma and IT Stocks with a strong future roadmap: Paras Defence and Space Technologies, Eris Lifesciences and Tech Mahindra. Compare price, valuation, return on equity and revenue growth as of 9 November 2026.<\/p>\n","protected":false},"author":36,"featured_media":343056,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[3803,21762,5451,21761,13903,21760,18717,8622,21759,614],"class_list":["post-343057","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-best-stocks","tag-branded-drug-and-telecom-software-stocks","tag-defence-electronics","tag-drone-optics","tag-eris-lifesciences","tag-medicine-and-technology-shares","tag-optics","tag-paras-defence-and-space-technologies","tag-pharma-and-it-stocks","tag-tech-mahindra"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["343056"],"rank_math_title":["Defence Electronics, Pharma and IT Stocks"],"rank_math_description":["Compare 3 defence electronics, pharma and IT stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 9 Nov 2026."],"rank_math_focus_keyword":["defence electronics, pharma and IT stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-defence-and-space-optics-company-pharmaceutical-company-and-global-it-services.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=343057"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343057\/revisions"}],"predecessor-version":[{"id":343058,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343057\/revisions\/343058"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/343056"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=343057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=343057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=343057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}